Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Anika Therapeutics
ANIK
$277M
| $2.62M | ﹤0.01% |
104,150
+2,580
| +3% | +$78.7K |
|
|
JOYY
2552
JOYY Inc
JOYY
$3.73B
| $2.61M | ﹤0.01% |
70,969
+2,743
| +4% | +$124K |
|
2553
Rigel Pharmaceuticals
RIGL
$693M
| $2.6M | ﹤0.01% |
87,069
+2,776
| +3% | +$75.2K |
|
|
ZEUS
2554
DELISTED
Olympic Steel
ZEUS
| $2.6M | ﹤0.01% |
67,656
+43,079
| +175% | +$1.16M |
|
2555
Praxis Precision Medicines
PRAX
$8.52B
| $2.6M | ﹤0.01% |
16,945
+428
| +3% | +$87.9K |
|
2556
Frontier Group Holdings
ULCC
$1.77B
| $2.6M | ﹤0.01% |
228,975
+5,452
| +2% | +$68.5K |
|
2557
Scholar Rock
SRRK
$5.49B
| $2.57M | ﹤0.01% |
199,551
+5,450
| +3% | +$93.1K |
|
2558
Holley
HLLY
$332M
| $2.57M | ﹤0.01% |
184,857
+4,596
| +3% | +$59K |
|
2559
908 Devices
MASS
$345M
| $2.56M | ﹤0.01% |
134,443
+27,090
| +25% | +$466K |
|
|
DCPH
2560
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.55M | ﹤0.01% |
275,329
-18,971
| -6% | -$161K |
|
|
OLPX
2561
DELISTED
Olaplex Holdings
OLPX
| $2.55M | ﹤0.01% |
163,111
+3,004
| +2% | +$57.3K |
|
|
BOXD
2562
DELISTED
Boxed, Inc.
BOXD
| $2.55M | ﹤0.01% |
+251,154
| New | +$2.56M |
|
2563
MediaAlpha
MAX
$781M
| $2.55M | ﹤0.01% |
153,903
+3,145
| +2% | +$44K |
|
2564
REX American Resources
REX
$1.42B
| $2.55M | ﹤0.01% |
153,360
+33,942
| +28% | +$549K |
|
|
SOVO
2565
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $2.53M | ﹤0.01% |
178,431
+4,951
| +3% | +$66.2K |
|
2566
Janus International
JBI
$739M
| $2.53M | ﹤0.01% |
280,923
+18,500
| +7% | +$188K |
|
2567
KRONOS Worldwide
KRO
$708M
| $2.48M | ﹤0.01% |
160,013
+5,253
| +3% | +$78.1K |
|
2568
Entravision Communication
EVC
$1.02B
| $2.48M | ﹤0.01% |
386,098
+5,026
| +1% | +$31.2K |
|
|
ADTH
2569
DELISTED
AdTheorent Holding Co
ADTH
| $2.48M | ﹤0.01% |
+251,479
| New | +$1.76M |
|
|
APPH
2570
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $2.47M | ﹤0.01% |
460,245
+9,487
| +2% | +$39.3K |
|
|
AKRO
2571
DELISTED
Akero Therapeutics
AKRO
| $2.46M | ﹤0.01% |
173,546
-706
| -0.4% | -$12.4K |
|
2572
Autohome
ATHM
$2.68B
| $2.46M | ﹤0.01% |
80,984
-2,297
| -3% | -$69.6K |
|
2573
Purple Innovation
PRPL
$39.2M
| $2.46M | ﹤0.01% |
16,819
+436
| +3% | +$85.9K |
|
2574
BRC Inc
BRCC
$123M
| $2.45M | ﹤0.01% |
+117,575
| New | +$2.08M |
|
2575
Gevo
GEVO
$355M
| $2.44M | ﹤0.01% |
522,235
+13,777
| +3% | +$52.7K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.